We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advances in Antibody Screening

Article  
Last Updated: March 25, 2022 
Written by 
Joanna Owens, PhD
Advances in Antibody Screening content piece image
Credit: iStock.
The rapid evolution of discovery workflows is reshaping how researchers identify high-value antibody candidates. Yet growing molecular complexity and data volume create bottlenecks that slow progress. These pressures highlight the need for precise, scalable selection methods. 

This article explores emerging approaches that streamline screening, improve accuracy and support faster decision making. 

 
Meet the Author
A greyscale headshot of Joanna Owens
Joanna Owens, PhD
Director of Faraday Science Communications
Joanna brings more than 20 years’ experience writing about a wide range of scientific topics in biosciences, pharmaceuticals and biotechnology. After a PhD in Molecular Toxicology, Joanna began a career in science publishing, as associate editor on Drug Discovery Today and later as senior editor, Nature Reviews Drug Discovery. In 2007, she joined one of the world’s largest biomedical charities, Cancer Research UK, specializing in plain language science communications for patients and the public. Joanna has been a freelance writer since 2017, covering all biomedical topics with a focus on oncology, pharmacology and drug discovery.
View this Article for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Experiencing issues viewing the form? Click here to access an alternate version
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter